PUM3

PUM3 (hPuf-A/KIAA0020) is a nucleolar RNA-binding protein built from six Puf-repeat domains that fold into a superhelical half-doughnut RNA-binding surface, and it functions in ribosome biogenesis and the cellular response to genotoxic stress (PMID:19319195, PMID:21266351). In the nucleolus, PUM3 participates in maturation of 7S to 5.8S rRNA (PMID:34407138) and physically associates with nucleophosmin (NPM1); loss of PUM3 displaces NPM1 to the nucleoplasm, traps ribosomal proteins S6 and L5 in the nucleolus, reduces 80S ribosome levels, and triggers cell-cycle arrest and death (PMID:34999733). Upon RNA polymerase or topoisomerase inhibition, PUM3 redistributes from nucleolus to nucleoplasm, where it binds the catalytic domain of PARP-1 and inhibits its poly(ADP-ribosyl)ation activity, thereby limiting caspase-3-mediated PARP-1 cleavage under genotoxic stress (PMID:21266351). PUM3 protein stability and its pro-proliferative function require phosphorylation at tyrosine Y259 (PMID:34407138). The NPM1-dependent ribosome biogenesis role is required in vivo for primordial germ cell survival and migration, where PUM3 loss hyperactivates p53 and induces apoptosis (PMID:35563782), though PUM3 is dispensable for mouse oocyte maturation and early embryo development in vitro (PMID:37194574).

1. 2009 Medium

   Establishing the molecular nature of PUM3 — what kind of protein it is and whether it binds RNA — was the foundational question, answered by structural modeling and biochemistry of the zebrafish ortholog.

   Evidence Computational structural modeling, RNA pull-down, and morpholino knockdown in zebrafish

   PMID:19319195

   Open questions at the time

   • RNA targets/sequence specificity not defined
   • structure based on modeling, not experimental structure
   • phenotypes from ortholog, not human protein
2. 2011 High

   Linking PUM3 to stress signaling: its nucleolar localization and genotoxic-stress-induced relocalization, plus direct inhibition of PARP-1, established a role beyond the nucleolus in the DNA-damage response.

   Evidence Immunofluorescence/fractionation with drug treatments, pull-down/MS, domain-mapped Co-IP, in vitro PARylation assay, and KD/OE with CPT/UV in human cells

   PMID:21266351

   Open questions at the time

   • trigger/mechanism of nucleolar-to-nucleoplasmic relocalization unresolved
   • whether PARP-1 inhibition occurs in vivo at endogenous levels unclear
   • structural basis of PUM3-PARP-1 catalytic domain binding not determined
3. 2021 Medium

   Defining a concrete nucleolar function and a regulatory switch: PUM3 was shown to act in 7S-to-5.8S rRNA processing, and Y259 phosphorylation was identified as required for its stability and proliferative function.

   Evidence CRISPR/Cas9 knockout with rRNA processing analysis and Y259F phosphomutant rescue/clonogenic assays in HeLa cells

   PMID:34407138

   Open questions at the time

   • kinase responsible for Y259 phosphorylation unknown
   • mechanism by which PUM3 contributes to rRNA processing not defined
   • single-lab single-method evidence
4. 2022 High

   Identifying the partner that mechanistically connects PUM3 to ribosome biogenesis: NPM1 interaction, whose disruption mislocalizes NPM1 and ribosomal proteins and collapses 80S assembly.

   Evidence Reciprocal Co-IP, IF co-localization, sucrose-gradient ribosome profiling, and shRNA KD/rescue in lung cancer cells plus mouse model

   PMID:34999733

   Open questions at the time

   • whether NPM1 binding is direct or RNA-mediated not resolved
   • interface/domain of the PUM3-NPM1 interaction not mapped
5. 2022 Medium

   Testing physiological relevance in vivo: the PUM3-NPM1 axis was shown to be required for primordial germ cell survival and migration via suppression of p53-driven apoptosis.

   Evidence Inducible shRNA transgenic mice, IF, flow cytometry, and Oct4-EGFP PGC tracking

   PMID:35563782

   Open questions at the time

   • how nucleolar stress activates p53 specifically in PGCs not detailed
   • knockdown rather than full knockout
6. 2023 Medium

   Delineating the boundaries of PUM3 requirement: it is dispensable for mouse oocyte maturation and early embryo development in vitro, indicating context-specific essentiality.

   Evidence siRNA microinjection into mouse GV oocytes with in vitro maturation, fertilization, and embryo culture readouts

   PMID:37194574

   Open questions at the time

   • incomplete knockdown could mask requirement
   • in vitro conditions may not reflect in vivo demands
   • negative result not extended to later development

• The endogenous RNA targets of PUM3 and the structural/mechanistic basis by which it both supports rRNA processing/NPM1-dependent ribosome assembly and inhibits PARP-1 remain unresolved.
• no defined cellular RNA target set
• no experimental structure of PUM3 or its complexes
• kinase upstream of Y259 unidentified